Issue : The Pharmaceutical Journal, May, Vol 298, No 7901
Sort by: Newest first Oldest first A-Z Z-A
-
Three decades of Viagra
Sildenafil (Viagra) — the first oral drug for erectile dysfunction to hit the market in 1998 — has been prescribed for more than 64 million men worldwide, and may soon be reclassified as a pharmacy medicine in the UK.
-
Sustainability and transformation plans: is pharmacy's voice being heard? Subscription
Sustainability and transformation plans (STPs) are the blueprints for the future of the NHS, setting out how 44 areas across England — identified as geographical STP ‘footprints’ — plan to get the best health outcomes for their populations from increasingly stretched financial resources.
-
Whooping cough: public health management and guidance Subscription
Pertussis (whooping cough) is a highly contagious, acute bacterial infection. It can affect people of all ages, but is especially dangerous in vulnerable groups, such as unimmunised infants.
-
Welsh Pharmacy Board meeting: 3 May 2017 Subscription
At the Welsh Pharmacy Board’s second meeting of 2017, members discussed the value of consultation responses and RPS campaigns, and changes to models of local engagement.
-
Scottish Pharmacy Board meeting: 26 April 2017 Subscription
At the second quarterly meeting of the Scottish Pharmacy Board members discussed antimicrobial stewardship, new ‘cross-sector’ vocational training for community pharmacists, and heard from representatives of the British Pharmaceutical Students’ Association.
-
English Pharmacy Board meeting: 5 April 2017 Subscription
The Royal Pharmaceutical Society English Pharmacy Board’s second quarterly open meeting of 2017 was held at the School of Pharmacy, University of Nottingham on 5 April 2017.
-
Reclassifying erectile dysfunction drug sildenafil as a P medicine not such a huge leap Subscription
Allowing pharmacists to sell sildenafil would offer men a convenient, safe, and perhaps less intimidating, channel for seeking professional advice and treatment for erectile dysfunction.
-
Pharmacist independent prescribers can make a significant contribution to antimicrobial stewardship Subscription
Karen Hodson, member of the Welsh Pharmacy Board, and colleagues discuss their experiences of how pharmacist prescribers can help in antimicrobial stewardship.
-
Design for dispensing: how far can we go to make packaging safer? Subscription
It is a decade since the National Patient Safety Agency issued guidance on medicines packaging design in a bid to reduce the risk of dispensing errors. But medicines that sound alike or look alike are still responsible for a large proportion of errors. A collaborative approach between manufacturers, regulators and pharmacy organisations is required to tackle the problem.
-
NHS cyber attack: views from the front line Subscription
The Pharmaceutical Journal spoke to pharmacists to find out how the cyber attack of 12 May 2017 affected their service provision and what they did to manage the situation.
-
How drug prices are hiked and what is being done to tackle the problem Subscription
There has been negative publicity in the national press about drug manufacturers increasing the price of some medicines significantly: so called ‘price gouging’. These increased prices are then passed on to the NHS, and lead to headlines quoting multi-million pound figures.
-
Heart attack risk raised in week after respiratory infection, say researchers
The risk of having a heart attack is 17 times higher in the week after a respiratory infection and remains high for a month, say Australian researchers.
-
Large pharmacy chains to set up 'crisis team' following cyber attack on NHS
The Company Chemists’ Association (CCA), a trade body that represents multiple pharmacy chains in the UK, is planning to set up a ‘crisis team’ in the wake of the malware attack that hit the NHS on 12 May 2017.
-
Facilitating anticipatory prescribing in end-of-life care Subscription
Anticipatory prescribing enables patients in the last days and weeks of their lives to have their symptoms managed at home. Pharmacists are ideally positioned to provide practical support and advice to other healthcare professionals on the prescribing and administration of anticipatory medicines and to facilitate timely supply.
-
Drugs for PTSD linked to increased risk of dementia
Certain psychotropic drugs used to treat post-traumatic stress disorder (PTSD) increase the risk of developing dementia, including in patients who do not have PTSD but take the drugs for other conditions, study results published in the Journal of the American Geriatrics Society show.
-
ICO report warns pharmacies about data protection breaches
Losing confidential personal data when transferring patient records is one of the data protection breaches committed by community pharmacists, according to the Information Commissioner’s Office’s good practice department.
-
Alcohol addiction drug may help treat stuttering
A drug which faced controversy over its unlicensed use in treating alcohol addiction might also be useful in stuttering, researchers have found.
-
A barrier to progress: getting drugs to the brain Subscription
Getting drugs across the blood-brain barrier could be key to developing more successful therapies to treat central nervous system disorders, such as Alzheimer’s disease, depression and epilepsy. Scientists are investigating a number of ways to achieve this, from using Trojan horses to smuggle drugs across the barrier, to temporary disruption of the barrier using ultrasound, to allow drugs into the brain.
-
Chief pharmaceutical officer of England ought to be congratulated Subscription
From Graham Phillips’s letter about his attendance at the ‘Quality for patients: pharmacy practice now and in the future’ conference (The Pharmaceutical Journal 2017;298:234), I thought he was going to report on the conference but all he offered was a rant at the chief pharmaceutical officer (CPO) for England for, in his view, inadequate ...
Show 10 per page20 per page50 per page
